PSFE:NYSEPaysafe Limited Analysis
Data as of 2026-05-31 - not real-time
$7.73
Latest Price
8/10Risk
Risk Level: High
Executive Summary
Paysafe Limited (PSFE) is trading around $7.73, well below its DCF‑derived fair value of $32.28, implying roughly a 30% upside potential. Revenue grew 10% YoY to $442.7 M and beat consensus estimates, while adjusted EPS of $0.41 topped the $0.39 forecast, reinforcing the recent earnings momentum. However, the company still posts a negative profit margin (‑11%) and thin operating margins (2.4%), with a high debt‑to‑equity ratio of over 400, suggesting significant leverage concerns. Technical indicators are mixed: the 20‑day SMA (8.26) sits above the current price, the MACD is bearish, and RSI is neutral at 45, but volume is increasing and price holds above the $6.76 support level.
The valuation picture is compelling: a forward P/E of about 3 versus an industry average of ~42, a price‑to‑book of 0.64, and a low price‑to‑sales multiple of 0.23 point to the stock being undervalued. Nonetheless, the high beta (≈2.5), 30‑day volatility over 69%, and a historic max drawdown of ~‑59% signal elevated market risk. Recent positive news around earnings beats and reaffirmed guidance may provide short‑term catalyst, but the heavy debt load and margin pressure remain key headwinds for medium‑ to long‑term investors.
The valuation picture is compelling: a forward P/E of about 3 versus an industry average of ~42, a price‑to‑book of 0.64, and a low price‑to‑sales multiple of 0.23 point to the stock being undervalued. Nonetheless, the high beta (≈2.5), 30‑day volatility over 69%, and a historic max drawdown of ~‑59% signal elevated market risk. Recent positive news around earnings beats and reaffirmed guidance may provide short‑term catalyst, but the heavy debt load and margin pressure remain key headwinds for medium‑ to long‑term investors.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Quarterly earnings beat and revenue beat
- Price near strong support with increasing volume
- Substantial upside relative to current price
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained top‑line growth and improving adjusted EBITDA
- Undervaluation metrics (low P/E, P/B, P/S) versus peers
- Potential debt reduction through operating cash flow
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High leverage and thin profit margins
- Exposure to regulatory changes in payments and iGaming
- Long‑term cash‑flow generation potential if margins improve
Key Metrics & Analysis
Financial Health
Revenue Growth10.40%
Profit Margin-11.44%
P/E Ratio3.0
ROE-26.99%
ROA1.56%
Debt/Equity411.10
P/B Ratio0.6
Op. Cash Flow$247.5M
Free Cash Flow$192.1M
Industry P/E41.9
Technical Analysis
TrendNeutral
RSI45.6
Support$6.76
Resistance$10.04
MA 20$8.26
MA 50$7.97
MA 200$9.29
MACDBearish
VolumeIncreasing
Fear & Greed Index94.07
Valuation
Fair Value$32.28
Target Price$10.04
Upside/Downside29.88%
GradeUndervalued
TypeGrowth
Risk Assessment
Beta2.49
Volatility69.05%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.